The first Korean case with Floating-Harbor syndrome with a novel SRCAP mutation diagnosed by targeted exome sequencing |
Choi, Eun Mi
(Department of Pediatrics, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine)
Lee, Dong Hyun (Department of Pediatrics, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine) Kang, Seok Jin (Department of Pediatrics, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine) Shim, Ye Jee (Department of Pediatrics, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine) Kim, Heung Sik (Department of Pediatrics, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine) Kim, Joon Sik (Department of Pediatrics, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine) Jeong, Jong In (Department of Otorhinolaryngology, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine) Ha, Jung-Sook (Department of Laboratory Medicine, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine) Jang, Ja-Hyun (Green Cross Genome) |
1 | Hood RL, Schenkel LC, Nikkel SM, Ainsworth PJ, Pare G, Boycott KM, et al. The defining DNA methylation signature of Floating-Harbor Syndrome. Sci Rep 2016;6:38803. DOI |
2 | Gerundino F, Marseglia G, Pescucci C, Pelo E, Benelli M, Giachini C, et al. 16p11.2 de novo microdeletion encompassing SRCAP gene in a patient with speech impairment, global developmental delay and behavioural problems. Eur J Med Genet 2014;57(11-12):649-53. DOI |
3 | Kehrer M, Beckmann A, Wyduba J, Finckh U, Dufke A, Gaiser U, et al. Floating-Harbor syndrome: SRCAP mutations are not restricted to exon 34. Clin Genet 2014;85:498-9. DOI |
4 | Messina G, Atterrato MT, Dimitri P. When chromatin organisation floats astray: the Srcap gene and Floating-Harbor syndrome. J Med Genet 2016;53:793-797. DOI |
5 | Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA, et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet 2011;12:745-55. DOI |
6 | Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-24. DOI |
7 | Nikkel SM, Dauber A, de Munnik S, Connolly M, Hood RL, Caluseriu O, et al. The phenotype of Floating-Harbor syndrome: clinical characterization of 52 individuals with mutations in exon 34 of SRCAP. Orphanet J Rare Dis 2013;8:63. DOI |
8 | Hood RL, Lines MA, Nikkel SM, Schwartzentruber J, Beaulieu C, Nowaczyk MJ, et al. Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome. Am J Hum Genet 2012;90:308-13. DOI |
9 | Roelfsema JH, White SJ, Ariyurek Y, Bartholdi D, Niedrist D, Papadia F, et al. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet 2005;76:572-80. DOI |
10 | Seifert W, Meinecke P, Kruger G, Rossier E, Heinritz W, Wusthof A, et al. Expanded spectrum of exon 33 and 34 mutations in SRCAP and follow-up in patients with Floating-Harbor syndrome. BMC Med Genet 2014;15:127. |
11 | Wiley S, Swayne S, Rubinstein JH, Lanphear NE, Stevens CA. Rubinstein-Taybi syndrome medical guidelines. Am J Med Genet A 2003; 119A:101-10. DOI |
12 | Nagasaki K, Asami T, Sato H, Ogawa Y, Kikuchi T, Saitoh A, et al. Long-term follow-up study for a patient with Floating-Harbor syndrome due to a hotspot SRCAP mutation. Am J Med Genet A 2014; 164A:731-5. |
13 | Le Goff C, Mahaut C, Bottani A, Doray B, Goldenberg A, Moncla A, et al. Not all floating-harbor syndrome cases are due to mutations in exon 34 of SRCAP. Hum Mutat 2013;34:88-92. DOI |